Procurement Summary
Country : Philippines
Summary : Essential Drugs (Early Procurement Activity)
Deadline : 10 Dec 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 110212030
Document Ref. No. : PB-DM(ED)-2025-017
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : PHP 53227751.40
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Tender are invited for ESSENTIAL DRUGS (Early Procurement Activity)
Product/Service Name : Acetylcysteine, Adenosine, Albumin, Human, Allopurinol, Aluminum Hydroxide, Alteplase, Amiodarone Hydrochloride, Aminophylline, Amlodipine, Aspirin, Ascorbic Acid, Atenolol, Atorvastatin Calcium, Atropine Sulfate, Baclofen, Beractant, Betahistine, Bisacodyl, Budesonide, Butamirate Citrate, Butorphanol tartrate, Calcium Carbonate, Calcium Gluconate, Calcitriol, Captopril, Carvedilol, Celecoxib, Cetirizine, Cilostazol, Cinnarizine, Clobetasol Propionate, Clonidine HCl, Clopidogrel, Colchicine, Dexamethasone, Digoxin, Diltiazem HCl, Diphenhydramine HCL, Diphenhydramine HCl, Divalproex sodium, Dobutamine Hydrochloride, Domperidone, Dopamine Hydrochloride, Dydrogesterone, Enalapril maleate, Enoxaparin sodium, Eperisone hydrochloride, Epinephrine HCl, Esmolol hydrochloride, Felodipine, Fenofibrate, Ferrous Salt + Folic Acid, Ferrous Sulfate, Finasteride, Fluticasone Propionate, Folic acid, Fondaparinux Sodium, Furosemide, Gabapentin, Gliclazide, Gliclazide MR, Glycerin (glycerol), Heparin sodium, Hydralazine Hydrochloride, Hydrochlorothiazide, Hydrocortisone Sodium Succinate, Hydroxychloroquine Sulfate, Hyoscine N-ButylBromide, Ibuprofen, Insulin Glargine, Insulin human, Insulin human 70/30, Ipratropium, Irbesartan + Hydrochlorothiazide, Iron sucrose, Isosorbide-5-Mononitrate, Isosorbide Dinitrate, Isoxsuprine, Ketoconazole, Ketorolac as tromethanol, Lactulose, Lagundi, Levetiracetam, Lev...
Documents
Tender Notice